SIGA - SIGA Technologies, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
About SIGA Technologies, Inc. (https://www.siga.com)
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Diem Nguyen | Chief Executive Officer & Director | 1972 | $1,390,500 USD |
| Daniel J. Luckshire | Executive Vice President, Chief Financial Officer & Secretary | 1971 | $1,316,441 USD |
| Dennis E. Hruby | Executive Vice President & Chief Scientific Officer | 1952 | $1,309,922 USD |
| Lawrence Miller | General Counsel & Corporate Secretary | 1968 | $1,042,875 USD |
| Herb Vloedman | Senior Vice President & Chief Information Officer | – | – |